S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.82%) $83.16
Gas
(-1.16%) $1.619
Gold
(-0.47%) $2 336.10
Silver
(-0.13%) $27.50
Platinum
(0.56%) $927.30
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.18%) $11.00
USD/GBP
(-0.25%) $0.798
USD/RUB
(0.00%) $92.17

リアルタイムの更新: ALK-Abelló A/S [AKABY]

取引所: OTC セクター: Healthcare 産業: Biotechnology
最終更新日時1 1月 1970 @ 09:00

0.00% $ 90.00

Live Chart Being Loaded With Signals

Commentary (1 1月 1970 @ 09:00):

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar...

Stats
本日の出来高 309.00
平均出来高 23.00
時価総額 0.00
Last Dividend $0.145 ( 2017-03-15 )
Next Dividend $0 ( N/A )
P/E 3 000.00
ATR14 $0 (0.00%)

ALK-Abelló A/S 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

ALK-Abelló A/S 財務諸表

Annual 2021
収益: $3.92B
総利益: $2.40B (61.18 %)
EPS: $0.200
FY 2021
収益: $3.92B
総利益: $2.40B (61.18 %)
EPS: $0.200
FY 2020
収益: $3.49B
総利益: $2.03B (58.09 %)
EPS: $0.0229
FY 2019
収益: $3.27B
総利益: $1.89B (57.79 %)
EPS: $-0.0459

Financial Reports:

No articles found.

ALK-Abelló A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

ALK-Abelló A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.33 - good (83.35%) | Divividend Growth Potential Score: 2.89 - No dividend growth expected in the near future
Information
First Dividend $0.152 2015-03-25
Last Dividend $0.145 2017-03-15
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out $0.448 --
Avg. Dividend % Per Year 0.00% --
Score 2.21 --
Div. Sustainability Score 8.33
Div.Growth Potential Score 2.89
Div. Directional Score 5.61 --
Next Divdend (Est)
(2024-12-30)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.21
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RWCB Ex Dividend Knight 2023-07-28 Quarterly 0 0.00%
FIDS Ex Dividend Junior 2023-05-18 Annually 0 0.00%
WEGZY Ex Dividend Knight 2023-09-29 Bi-Monthly 0 0.00%
MAORF Ex Dividend Junior 2023-08-17 Sporadic 0 0.00%
CLZNY Ex Dividend Knight 2023-06-09 Annually 0 0.00%
SNMCY Ex Dividend Junior 2023-08-18 Semi-Annually 0 0.00%
HCBC Ex Dividend Knight 2023-08-10 Quarterly 0 0.00%
AMFC Ex Dividend Knight 2023-08-31 Annually 0 0.00%
NHYDY Ex Dividend Knight 2023-05-11 Annually 0 0.00%
CSXXY Ex Dividend Knight 2023-09-15 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05591.5008.8810.00[0 - 0.5]
returnOnAssetsTTM0.03761.2008.7510.00[0 - 0.3]
returnOnEquityTTM0.06601.500-0.377-0.566[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.7350.8006.325.06[1 - 3]
quickRatioTTM0.1400.800-3.88-3.11[0.8 - 2.5]
cashRatioTTM0.1401.500-0.333-0.499[0.2 - 2]
debtRatioTTM0.122-1.5007.97-10.00[0 - 0.6]
interestCoverageTTM13.131.0006.256.25[3 - 30]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
freeCashFlowPerShareTTM0.1862.009.9110.00[0 - 20]
debtEquityRatioTTM0.204-1.5009.18-10.00[0 - 2.5]
grossProfitMarginTTM0.6121.0003.143.14[0.2 - 0.8]
operatingProfitMarginTTM0.07711.000-0.458-0.458[0.1 - 0.6]
cashFlowToDebtRatioTTM0.6591.0007.457.45[0.2 - 2]
assetTurnoverTTM0.6720.8008.867.08[0.5 - 2]
Total Score8.33

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3 150.681.00010.000[1 - 100]
returnOnEquityTTM0.06602.50-0.243-0.566[0.1 - 1.5]
freeCashFlowPerShareTTM0.1862.009.9410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-22.591.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1201.0009.510[0.1 - 0.5]
Total Score2.89

ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。